mitogen-activated protein kinase 14

Summary
Gene Symbol
  • MAPK14
Organism
Homo sapiens (human)
NCBI Gene
1432
PubChem
1432
Alliance of Genome Resources
Annotation
Keyword
  • 3D-structure
  • ATP-binding
  • Acetylation
  • Alternative splicing
  • Apoptosis
  • Cytoplasm
  • Direct protein sequencing
  • Kinase
  • Nucleus
  • Phosphoprotein
  • Proteomics identification
  • Reference proteome
  • Serine/threonine-protein kinase
  • Stress response
  • Transcription regulation
  • Ubl conjugation
Proteins
Displaying all 3 entries
UniProt Protein Name
B4E0K5
Q16539
  • Cytokine suppressive anti-inflammatory drug-binding protein
  • MAP kinase MXI2
  • MAX-interacting protein 2
  • Mitogen-activated protein kinase p38 alpha
  • Stress-activated protein kinase 2a
L7RSM2
  • Mitogen-activated protein kinase p38 alpha
Gene Ontology (GO)
GO Hierarchy
GO Hierarchy
OrthoDB (Group)
Group level
Eukaryota
Group Name
Mitogen-activated protein kinase 14
Functional Category
  • M: Cell wall/membrane/envelope biogenesis
  • O: Posttranslational modification, protein turnover, chaperones
  • T: Signal transduction mechanisms
Disease
Disease Ontology
Displaying entries 1 - 10 of 11 in total
DO ID Disease Name Source
DOID:0080199 colorectal carcinoma
DOID:10652 Alzheimer's disease
DOID:11476 osteoporosis
DOID:13949 interstitial cystitis
DOID:14330 Parkinson's disease
DOID:1993 rectum cancer
DOID:219 colon cancer
DOID:3717 gastric adenocarcinoma
DOID:4780 anti-basement membrane glomerulonephritis
DOID:9261 nasopharynx carcinoma

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024